[ad_1] CAMBRIDGE, Mbad., July 9, 2018 (GLOBE NEWSWIRE) – VBI Vaccines Inc. (Nasdaq: VBIV) ("VBI"), a commercial biopharmaceutical company developing next-generation vaccines against infectious and immuno-oncological diseases , announced today that the …
Read More »